THRN — Thorne HealthTech Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid Cap

Annual income statement for Thorne HealthTech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	C2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS/A	PROSPECTUS/A	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Revenue
Total Revenue	103	138	184	229
Cost of Revenue
Gross Profit	44.7	64.8	96.4	115
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	116	137	175	223
Operating Profit	-13.9	1.01	9.59	5.48
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-16.6	-2.27	10.9	7.8
Provision for Income Taxes
Net Income After Taxes	-16.6	-2.44	10.5	15.1
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	-16.7	-3.36	7.25	15.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-21.5	-3.36	3.75	15.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-211	-32.8	0.104	0.303
Dividends per Share